Active, not recruiting
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation
NCT04203316
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center Denver, Colorado, United States